# INLYTA
> **NDA202324** · New Drug Application · Sponsor: PF PRISM CV · Approved 2012-01-27
## Drug
- **FDA Application Number:** NDA202324
- **Application type:** New Drug Application
- **Brand name:** INLYTA
- **Generic name:** AXITINIB
- **Active ingredients:** AXITINIB
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PF PRISM CV
- **Manufacturer:** U.S. Pharmaceuticals
- **First approval:** 2012-01-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202324)
---
*MORVS · CC0 1.0*